The Federal Institute for Drugs and Medical Devices (BfArM) has published the final version of OPS 2026 - an important step for all stakeholders in the healthcare sector.
With over 156 incorporated proposals, this version brings significant innovations for the OPS classification.
As experts in market access and reimbursement, we can help you make the most of the impact of the new OPS version 2026 on your billing processes and reimbursement strategies.
Get in touch with us and use our expertise to your advantage!
Author: Healthcare Heads GmbH
Phone: +49 431 800 1470
E-Mail: info@healthcareheads.com